Platform study of circulating tumor DNA–directed adjuvant chemotherapy in colon cancer (CLAUDIA Colon Cancer, KCSG CO22-12). A precision medicine trial leveraging tissue and blood-based tumor genomics ...
Neoadjuvant botensilimab plus balstilimab in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial. This is an ASCO Meeting Abstract from the 2024 ASCO ...
Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new ...
A long-standing debate over the most effective treatment for prevalent forms of colorectal cancer — the world’s third most diagnosed cancer — was finally settled in June 2022. The much-anticipated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results